| Full Name | Ben Adams |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 8166 Main St, Houma, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366659872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | DO.000173 (Louisiana) | Primary |
| 207L00000X | Anesthesiology | 0102201937 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usa Health University Hospital | Mobile, AL | Hospital |
| Terrebonne General Medical Center | Houma, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paeon Health Services Inc | 1153697727 | 41 |
| Usa Health Anesthesia Billing Services Llc | 1153659123 | 136 |
News Archive
In a world first, clinical researchers from the Universities of Manchester and Liverpool have collaborated with colleagues in south Asia to adapt a parent-led autism therapy and successfully tested it in India and Pakistan, with the aim of improving treatment for an estimated 5 million children in the region with the disorder.
Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.
› Verified 7 days ago
| Entity Name | Satyr Clinical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881019321 PECOS PAC ID: 2466673025 Enrollment ID: O20141023000763 |
News Archive
In a world first, clinical researchers from the Universities of Manchester and Liverpool have collaborated with colleagues in south Asia to adapt a parent-led autism therapy and successfully tested it in India and Pakistan, with the aim of improving treatment for an estimated 5 million children in the region with the disorder.
Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.
› Verified 7 days ago
| Entity Name | Paeon Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568985612 PECOS PAC ID: 1153697727 Enrollment ID: O20171026000630 |
News Archive
In a world first, clinical researchers from the Universities of Manchester and Liverpool have collaborated with colleagues in south Asia to adapt a parent-led autism therapy and successfully tested it in India and Pakistan, with the aim of improving treatment for an estimated 5 million children in the region with the disorder.
Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.
› Verified 7 days ago
| Entity Name | Anesthesia Associates Of Bayou Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679157887 PECOS PAC ID: 7416357934 Enrollment ID: O20210621000817 |
News Archive
In a world first, clinical researchers from the Universities of Manchester and Liverpool have collaborated with colleagues in south Asia to adapt a parent-led autism therapy and successfully tested it in India and Pakistan, with the aim of improving treatment for an estimated 5 million children in the region with the disorder.
Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ben Adams, DO 8166 Main St, Houma, LA 70360-3404 Ph: (985) 873-4235 | Ben Adams, DO 8166 Main St, Houma, LA 70360-3404 Ph: (985) 873-4235 |
News Archive
In a world first, clinical researchers from the Universities of Manchester and Liverpool have collaborated with colleagues in south Asia to adapt a parent-led autism therapy and successfully tested it in India and Pakistan, with the aim of improving treatment for an estimated 5 million children in the region with the disorder.
Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.
USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.
› Verified 7 days ago
Daniel M Whittington, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8166 Main Street, Houma, LA 70360 Phone: 985-873-4141 Fax: 985-751-4307 | |
Dr. Michael S Haydel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1022 Belanger St, Houma, LA 70360 Phone: 985-223-3132 Fax: 985-223-3126 | |
Drake A Degrange, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1990 Industrial Blvd, Houma, LA 70363 Phone: 985-868-9300 Fax: 985-851-0053 | |
Francis E Lewis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8166 Main Street, Houma, LA 70360 Phone: 985-873-4141 Fax: 985-851-4307 | |
Ms. Christin Cathia Gethers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1978 Industrial Blvd, Houma, LA 70363 Phone: 985-873-2200 | |
Elizabeth Gheisari, M.D Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1990 Industrial Blvd, Houma, LA 70363 Phone: 985-868-9300 Fax: 985-851-0053 | |
Joseph L Kellum Jr., MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8166 Main Street, Houma, LA 70360 Phone: 985-873-4141 Fax: 985-851-4307 |